BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ganaie F, Saad JS, McGee L, van Tonder AJ, Bentley SD, Lo SW, Gladstone RA, Turner P, Keenan JD, Breiman RF, Nahm MH. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus. mBio 2020;11:e00937-20. [PMID: 32430472 DOI: 10.1128/mBio.00937-20] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 26.5] [Reference Citation Analysis]
Number Citing Articles
1 Richardson NI, Kuttel MM, Ravenscroft N. Modeling of pneumococcal serogroup 10 capsular polysaccharide molecular conformations provides insight into epitopes and observed cross-reactivity. Front Mol Biosci 2022;9:961532. [DOI: 10.3389/fmolb.2022.961532] [Reference Citation Analysis]
2 Cleary DW, Jones J, Gladstone RA, Osman KL, Devine VT, Jefferies JM, Bentley SD, Faust SN, Clarke SC. Changes in serotype prevalence of Streptococcus pneumoniae in Southampton, UK between 2006 and 2018. Sci Rep 2022;12:13332. [PMID: 35922536 DOI: 10.1038/s41598-022-17600-6] [Reference Citation Analysis]
3 Desmet S, Theeten H, Laenen L, Cuypers L, Maes P, Bossuyt W, Van Heirstraeten L, Peetermans WE, Lagrou K. Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium. Emerg Infect Dis 2022;28:1606-14. [PMID: 35876488 DOI: 10.3201/eid2808.212440] [Reference Citation Analysis]
4 Chang B, Morita M, Nariai A, Kasahara K, Kakutani A, Ogawa M, Ohnishi M, Oishi K. Invasive Streptococcus oralis Expressing Serotype 3 Pneumococcal Capsule, Japan. Emerg Infect Dis 2022;28:1720-2. [PMID: 35876607 DOI: 10.3201/eid2808.212176] [Reference Citation Analysis]
5 Ayoola MB, Shack LA, Lee JH, Lim J, Eoh H, Swiatlo E, Phanstiel O 4th, Nanduri B. Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci. Sci Rep 2022;12:11804. [PMID: 35821246 DOI: 10.1038/s41598-022-16007-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang L, Wasserman M, Grant L, Farkouh R, Snow V, Arguedas A, Chilson E, Sato R, Perdrizet J. Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States. Vaccine 2022:S0264-410X(22)00773-3. [PMID: 35753839 DOI: 10.1016/j.vaccine.2022.06.024] [Reference Citation Analysis]
7 Huang LD, Yang MJ, Huang YY, Jiang KY, Yan J, Sun AH. Molecular Characterization of Predominant Serotypes, Drug Resistance, and Virulence Genes of Streptococcus pneumoniae Isolates From East China. Front Microbiol 2022;13:892364. [PMID: 35722327 DOI: 10.3389/fmicb.2022.892364] [Reference Citation Analysis]
8 Gong W, Liang M, Zhao J, Wang H, Chen Z, Wang F, Gu G. Biochemical Characterization and Synthetic Application of WciN and Its Mutants From Streptococcus pneumoniae Serotype 6B. Front Chem 2022;10:914698. [DOI: 10.3389/fchem.2022.914698] [Reference Citation Analysis]
9 Narciso AR, Iovino F, Thorsdottir S, Mellroth P, Codemo M, Spoerry C, Righetti F, Muschiol S, Normark S, Nannapaneni P, Henriques-Normark B. Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA. Proc Natl Acad Sci U S A 2022;119:e2122386119. [PMID: 35648835 DOI: 10.1073/pnas.2122386119] [Reference Citation Analysis]
10 Waz NT, Oliveira S, Girardello R, Lincopan N, Barazzone G, Parisotto T, Hakansson AP, Converso TR, Darrieux M. Influence of the Polysaccharide Capsule on the Bactericidal Activity of Indolicidin on Streptococcus pneumoniae. Front Microbiol 2022;13:898815. [DOI: 10.3389/fmicb.2022.898815] [Reference Citation Analysis]
11 Aceil J, Avci FY. Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets. Front Cell Infect Microbiol 2022;12:832254. [DOI: 10.3389/fcimb.2022.832254] [Reference Citation Analysis]
12 Tamura K, Chang B, Shimbashi R, Watanabe H, Tanabe Y, Kuronuma K, Oshima K, Maruyama T, Fujita J, Abe S, Kasahara K, Nishi J, Kubota T, Kinjo Y, Fujikura H, Fukusumi M, Shimada T, Sunagawa T, Suzuki M, Yamamoto Y, Oishi K; Adult IPD Study Group. Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019. Vaccine 2022:S0264-410X(22)00502-3. [PMID: 35489986 DOI: 10.1016/j.vaccine.2022.04.062] [Reference Citation Analysis]
13 Sempere J, Llamosí M, Román F, Lago D, González-Camacho F, Pérez-García C, Yuste J, Domenech M. Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-L-cysteine and cysteamine. Sci Rep 2022;12:6668. [PMID: 35461321 DOI: 10.1038/s41598-022-10609-x] [Reference Citation Analysis]
14 Wróbel-Pawelczyk I, Ronkiewicz P, Wanke-Rytt M, Rykowska D, Górska-Kot A, Włodkowska K, Topczewska-Cabanek A, Jackowska T, Chruszcz J, Marchut W, Mastalerz-Migas A, Korzeniewski K, Skoczyńska A, Trzciński K; GIL Study Team. Pneumococcal carriage in unvaccinated children at the time of vaccine implementation into the national immunization program in Poland. Sci Rep 2022;12:5858. [PMID: 35393439 DOI: 10.1038/s41598-022-09488-z] [Reference Citation Analysis]
15 An H, Qian C, Huang Y, Li J, Tian X, Feng J, Hu J, Fang Y, Jiao F, Zeng Y, Huang X, Meng X, Liu X, Lin X, Zeng Z, Guilliams M, Beschin A, Chen Y, Wu Y, Wang J, Oggioni MR, Leong J, Veening JW, Deng H, Zhang R, Wang H, Wu J, Cui Y, Zhang JR. Functional vulnerability of liver macrophages to capsules defines virulence of blood-borne bacteria. J Exp Med 2022;219:e20212032. [PMID: 35258552 DOI: 10.1084/jem.20212032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Eichner H, Karlsson J, Loh E. The emerging role of bacterial regulatory RNAs in disease. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yamba Yamba L, Uddén F, Fuursted K, Ahl J, Slotved H, Riesbeck K. Extensive/Multidrug-Resistant Pneumococci Detected in Clinical Respiratory Tract Samples in Southern Sweden Are Closely Related to International Multidrug-Resistant Lineages. Front Cell Infect Microbiol 2022;12:824449. [DOI: 10.3389/fcimb.2022.824449] [Reference Citation Analysis]
18 Mehanny M, Kroniger T, Koch M, Hoppstädter J, Becher D, Kiemer AK, Lehr CM, Fuhrmann G. Yields and Immunomodulatory Effects of Pneumococcal Membrane Vesicles Differ with the Bacterial Growth Phase. Adv Healthc Mater 2022;11:e2101151. [PMID: 34724354 DOI: 10.1002/adhm.202101151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Hsiao A, Hansen J, Timbol J, Lewis N, Isturiz R, Alexander-Parrish R, McLaughlin JM, Gessner BD, Klein NP. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine. JAMA Netw Open 2022;5:e221111. [PMID: 35302634 DOI: 10.1001/jamanetworkopen.2022.1111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gu Yoon J, Jang A, Ja Kim M, Bin Seo Y, Lee J, Hwa Choi Y, Keun Kim Y, Joo Jeong E, Soo Kim H, Tae Kwon K, Sik Jung D, Suk Choi W, Soo Lee J, Hwa Park K, Won Jeong H, hee Baik S, Hui Kang S, Bae I, Yun Noh J, Jin Cheong H, Joo Kim W, Young Song J. Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.03.004] [Reference Citation Analysis]
21 Perniciaro S, van der Linden M, Weinberger DM. Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021. Clin Infect Dis 2022:ciac100. [PMID: 35136983 DOI: 10.1093/cid/ciac100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Gingerich AD, Mousa JJ. Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies. Front Cell Infect Microbiol 2022;12:824788. [DOI: 10.3389/fcimb.2022.824788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Shi W, Du Q, Yuan L, Gao W, Wang Q, Yao K. Antibiotic Resistance and Molecular Biological Characteristics of Non-13-Valent-Pneumococcal Conjugate Vaccine Serogroup 15 Streptococcus pneumoniae Isolated From Children in China. Front Microbiol 2021;12:778985. [PMID: 35069480 DOI: 10.3389/fmicb.2021.778985] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhou M, Wang Z, Zhang L, Kudinha T, An H, Qian C, Jiang B, Wang Y, Xu Y, Liu Z, Zhang H, Zhang J. Serotype Distribution, Antimicrobial Susceptibility, Multilocus Sequencing Type and Virulence of Invasive Streptococcus pneumoniae in China: A Six-Year Multicenter Study. Front Microbiol 2022;12:798750. [DOI: 10.3389/fmicb.2021.798750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Theilacker C, Fletcher MA, Jodar L, Gessner BD. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Microorganisms 2022;10:127. [PMID: 35056576 DOI: 10.3390/microorganisms10010127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
26 Gaikwad WK, Jana SK, Dhere RM, Ravenscroft N, Kodam KM. Partial depolymerization of capsular polysaccharides isolated from Streptococcus pneumoniae serotype 2 by various methods. Carbohydrate Research 2022. [DOI: 10.1016/j.carres.2022.108503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Redin A, Ciruela P, de Sevilla MF, Gomez-Bertomeu F, Gonzalez-Peris S, Benitez MA, Trujillo G, Diaz A, Jou E, Izquierdo C, Perez-Moreno MO, Moraga-Llop F, Olsina M, Vinado B, Sanfeliu E, Garcia A, Gonzalez-di Lauro S, Garcia-Garcia JJ, Dominguez A, Sa-Leao R, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Microbiol Spectr 2021;9:e0115021. [PMID: 34878302 DOI: 10.1128/Spectrum.01150-21] [Reference Citation Analysis]
28 Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines 2021. [PMID: 34882050 DOI: 10.1080/14760584.2022.2012455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chaguza C, Yang M, Jacques LC, Bentley SD, Kadioglu A. Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms. Trends in Microbiology 2021. [DOI: 10.1016/j.tim.2021.11.007] [Reference Citation Analysis]
31 Oliveira GS, Oliveira MLS, Miyaji EN, Rodrigues TC. Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines (Basel) 2021;9:1338. [PMID: 34835269 DOI: 10.3390/vaccines9111338] [Reference Citation Analysis]
32 Al-Lahham A. Prevalence of Pneumococcal Carriage among Jordanian Infants in the First 6 Months of Age, 2008-2016. Vaccines (Basel) 2021;9:1283. [PMID: 34835213 DOI: 10.3390/vaccines9111283] [Reference Citation Analysis]
33 Wasserman MD, Perdrizet J, Grant L, Hayford K, Singh S, Saharia P, Horn EK, Farkouh RA. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infect Dis Ther 2021;10:2701-20. [PMID: 34633639 DOI: 10.1007/s40121-021-00544-1] [Reference Citation Analysis]
34 Chan KF, Ma TF, Ip MS, Ho PL. Invasive pneumococcal disease, pneumococcal pneumonia and all-cause pneumonia in Hong Kong during the COVID-19 pandemic compared with the preceding 5 years: a retrospective observational study. BMJ Open 2021;11:e055575. [PMID: 34635536 DOI: 10.1136/bmjopen-2021-055575] [Reference Citation Analysis]
35 Navarro-Torné A, Montuori EA, Kossyvaki V, Méndez C. Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis. Hum Vaccin Immunother 2021;17:3670-86. [PMID: 34106040 DOI: 10.1080/21645515.2021.1923348] [Reference Citation Analysis]
36 Betts M, Jarvis S, Jeffries A, Gori A, Chaguza C, Msefula J, Weight CM, Kwambana-Adams B, French N, Swarthout TD, Brown JS, Heyderman RS. Complete Genome Sequence of Streptococcus pneumoniae Strain BVJ1JL, a Serotype 1 Carriage Isolate from Malawi. Microbiol Resour Announc 2021;10:e0071521. [PMID: 34591678 DOI: 10.1128/MRA.00715-21] [Reference Citation Analysis]
37 Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack M. A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. Expert Rev Vaccines 2021;20:1311-25. [PMID: 34550850 DOI: 10.1080/14760584.2021.1984888] [Reference Citation Analysis]
38 Ouattara M, Tamboura M, Kambiré D, Lê KA, Van Phan T, Velusamy S, Nguyen HA, Trang DVT, Lessa FC, Iijima M, Nguyen DT, Schwartz SB, McGee L, Traoré RO, Beall B. Triplex Direct Quantitative Polymerase Chain Reaction for the Identification of Streptococcus pneumoniae Serotypes. J Infect Dis 2021;224:S204-8. [PMID: 34469558 DOI: 10.1093/infdis/jiab056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
39 Birindwa AM, Kasereka JK, Gonzales-Siles L, Geravandi S, Mwilo M, Tudiakwile LK, Mwinja NL, Muhigirwa B, Kashosi T, Manegabe JT, Bugashane EB, Saili SM, Mungo C, Nordén R, Andersson R, Skovbjerg S. Bacteria and viruses in the upper respiratory tract of Congolese children with radiologically confirmed pneumonia. BMC Infect Dis 2021;21:837. [PMID: 34412597 DOI: 10.1186/s12879-021-06570-1] [Reference Citation Analysis]
40 Li C, Andersen KB, Elverdal PL, Skovsted IC, Duus JØ, Kjeldsen C. Full NMR assignment, revised structure and biosynthetic analysis for the capsular polysaccharide from Streptococcus Pneumoniae serotype 15F. Carbohydr Res 2021;508:108418. [PMID: 34403973 DOI: 10.1016/j.carres.2021.108418] [Reference Citation Analysis]
41 Narwortey DK, Owusu-Ofori A, Slotved HC, Donkor ES, Ansah PO, Welaga P, Agongo G, Oduro AR. Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana. BMC Infect Dis 2021;21:661. [PMID: 34233627 DOI: 10.1186/s12879-021-06302-5] [Reference Citation Analysis]
42 Ekinci E, Desmet S, Van Heirstraeten L, Mertens C, Wouters I, Beutels P, Verhaegen J, Malhotra-Kumar S, Theeten H; NPcarriage Group. Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016-2019. Front Pediatr 2021;9:664083. [PMID: 34291017 DOI: 10.3389/fped.2021.664083] [Reference Citation Analysis]
43 Ganaie F, Maruhn K, Li C, Porambo RJ, Elverdal PL, Abeygunwardana C, van der Linden M, Duus JØ, Sheppard CL, Nahm MH. Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure. J Clin Microbiol 2021;59:e0054021. [PMID: 33883183 DOI: 10.1128/JCM.00540-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Walkowski W, Bassett J, Bhalla M, Pfeifer BA, Ghanem ENB. Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease. Vaccines (Basel) 2021;9:589. [PMID: 34199398 DOI: 10.3390/vaccines9060589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia (Nathan) 2021;13:9. [PMID: 34030731 DOI: 10.1186/s41479-021-00086-7] [Reference Citation Analysis]
46 Gertz RE Jr, Pimenta FC, Chochua S, Larson S, Venero AK, Bigogo G, Milucky J, Carvalho MDG, Beall B. Nonpneumococcal Strains Recently Recovered from Carriage Specimens and Expressing Capsular Serotypes Highly Related or Identical to Pneumococcal Serotypes 2, 4, 9A, 13, and 23A. mBio 2021;12:e01037-21. [PMID: 34006665 DOI: 10.1128/mBio.01037-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Bentley SD, Lo SW. Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics. Genome Med 2021;13:84. [PMID: 34001237 DOI: 10.1186/s13073-021-00901-2] [Reference Citation Analysis]
48 Hansen CB, Fuursted K, Valentiner-Branth P, Dalby T, Jørgensen CS, Slotved HC. Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 8 in Denmark. BMC Infect Dis 2021;21:421. [PMID: 33952197 DOI: 10.1186/s12879-021-06103-w] [Reference Citation Analysis]
49 Eichner H, Karlsson J, Spelmink L, Pathak A, Sham LT, Henriques-Normark B, Loh E. RNA thermosensors facilitate Streptococcus pneumoniae and Haemophilus influenzae immune evasion. PLoS Pathog 2021;17:e1009513. [PMID: 33914847 DOI: 10.1371/journal.ppat.1009513] [Reference Citation Analysis]
50 Morimura A, Hamaguchi S, Akeda Y, Tomono K. Mechanisms Underlying Pneumococcal Transmission and Factors Influencing Host-Pneumococcus Interaction: A Review. Front Cell Infect Microbiol 2021;11:639450. [PMID: 33996623 DOI: 10.3389/fcimb.2021.639450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Bedeley E, Gori A, Yeboah-Manu D, Diallo K. Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae. Front Microbiol 2021;12:658824. [PMID: 33967998 DOI: 10.3389/fmicb.2021.658824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines (Basel) 2021;9:420. [PMID: 33922273 DOI: 10.3390/vaccines9050420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Huang J, Gingerich AD, Royer F, Paschall AV, Pena-Briseno A, Avci FY, Mousa JJ. Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection. Infect Immun 2021;89:e00747-20. [PMID: 33649050 DOI: 10.1128/IAI.00747-20] [Reference Citation Analysis]
54 Dzaraly ND, Mohd Desa MN, Muthanna A, Masri SN, Taib NM, Suhaili Z, Sulaiman N, Baharin NHZ, Shuan CY, Ariffin Z, Rahman NIA, Mohd Rani F, Palanisamy NK, Soh TST, Abdullah FH. Antimicrobial susceptibility, serotype distribution, virulence profile and molecular typing of piliated clinical isolates of pneumococci from east coast, Peninsular Malaysia. Sci Rep 2021;11:8220. [PMID: 33859249 DOI: 10.1038/s41598-021-87428-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Félix S, Henares D, Muñoz-Almagro C, Sá-Leão R. Carriage of multiple Streptococcus pneumoniae capsular types is frequent among children with invasive pneumococcal disease. Eur J Clin Microbiol Infect Dis 2021;40:2397-401. [PMID: 33797644 DOI: 10.1007/s10096-021-04231-4] [Reference Citation Analysis]
56 Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arová L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muñoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyńska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K, The Pserenade Team. Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms 2021;9:696. [PMID: 33801760 DOI: 10.3390/microorganisms9040696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Nanduri B, Swiatlo E. The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniae. Pneumonia (Nathan) 2021;13:4. [PMID: 33762024 DOI: 10.1186/s41479-021-00082-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Chang B, Kinjo Y, Morita M, Tamura K, Watanabe H, Tanabe Y, Kuronuma K, Fujita J, Oshima K, Maruyama T, Abe S, Kasahara K, Nishi J, Kubota T, Ohnishi M, Suga S, Oishi K. Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan. Front Cell Infect Microbiol 2021;11:617573. [PMID: 33869075 DOI: 10.3389/fcimb.2021.617573] [Reference Citation Analysis]
59 Scott NR, Mann B, Tuomanen EI, Orihuela CJ. Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines. Vaccines (Basel) 2021;9:209. [PMID: 33801372 DOI: 10.3390/vaccines9030209] [Reference Citation Analysis]
60 Martín-Galiano AJ, Escolano-Martínez MS, Corsini B, Campa AG, Yuste J. Immunization with SP_1992 (DiiA) Protein of Streptococcus pneumoniae Reduces Nasopharyngeal Colonization and Protects against Invasive Disease in Mice. Vaccines (Basel) 2021;9:187. [PMID: 33668195 DOI: 10.3390/vaccines9030187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Corsini B, Aguinagalde L, Ruiz S, Domenech M, Yuste J. Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System. Vaccines (Basel) 2021;9:186. [PMID: 33672306 DOI: 10.3390/vaccines9020186] [Reference Citation Analysis]
62 Tsang RSW. A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Streptococcus agalactiae. Microorganisms 2021;9:449. [PMID: 33671611 DOI: 10.3390/microorganisms9020449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sempere J, Llamosí M, Del Río Menéndez I, López Ruiz B, Domenech M, González-Camacho F. Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates. Vaccines (Basel) 2021;9:181. [PMID: 33672701 DOI: 10.3390/vaccines9020181] [Reference Citation Analysis]
64 Reslan L, Finianos M, Bitar I, Moumneh MB, Araj GF, Zaghlout A, Boutros C, Jisr T, Nabulsi M, Kara Yaccoub G, Hamze M, Osman M, Bou Raad E, Hrabak J, Matar GM, Dbaibo G. The Emergence of Invasive Streptococcus pneumoniae Serotype 24F in Lebanon: Complete Genome Sequencing Reveals High Virulence and Antimicrobial Resistance Characteristics. Front Microbiol 2021;12:637813. [PMID: 33746930 DOI: 10.3389/fmicb.2021.637813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Izurieta P, Nieto Guevara J. Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Hum Vaccin Immunother 2021;:1-8. [PMID: 33605846 DOI: 10.1080/21645515.2021.1872341] [Reference Citation Analysis]
66 Yamaguchi M, Win HPM, Higashi K, Ono M, Hirose Y, Motooka D, Okuzaki D, Aye MM, Htun MM, Thu HM, Kawabata S. Epidemiological analysis of pneumococcal strains isolated at Yangon Children's Hospital in Myanmar via whole-genome sequencing-based methods. Microb Genom 2021;7. [PMID: 33565958 DOI: 10.1099/mgen.0.000523] [Reference Citation Analysis]
67 Buades J, Losada I, González-Moreno J, Peñaranda M, Vilaplana L, Roda N, Rey A, Rodriguez A, Garau M, de Gopegui ER, Serra A, Saurina J, Payeras A. Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old. Vaccines (Basel) 2021;9:93. [PMID: 33513726 DOI: 10.3390/vaccines9020093] [Reference Citation Analysis]
68 Du S, Vilhena C, King S, Sahagún-Ruiz A, Hammerschmidt S, Skerka C, Zipfel PF. Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic. Sci Rep 2021;11:1701. [PMID: 33462258 DOI: 10.1038/s41598-020-79362-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Chaguza C, Senghore M, Bojang E, Lo SW, Ebruke C, Gladstone RA, Tientcheu PE, Bancroft RE, Worwui A, Foster-Nyarko E, Ceesay F, Okoi C, McGee L, Klugman KP, Breiman RF, Barer MR, Adegbola RA, Antonio M, Bentley SD, Kwambana-Adams BA. Carriage Dynamics of Pneumococcal Serotypes in Naturally Colonized Infants in a Rural African Setting During the First Year of Life. Front Pediatr 2020;8:587730. [PMID: 33489998 DOI: 10.3389/fped.2020.587730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Bernth Jensen JM, Skeldal S, Petersen MS, Møller BK, Hoffmann S, Jensenius JC, Skov Sørensen UB, Thiel S. The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity. Immunology 2021;162:434-51. [PMID: 33340093 DOI: 10.1111/imm.13297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Bhalla M, Nayerhoda R, Tchalla EYI, Abamonte A, Park D, Simmons SR, Pfeifer BA, Bou Ghanem EN. Liposomal Encapsulation of Polysaccharides (LEPS) as an Effective Vaccine Strategy to Protect Aged Hosts Against S. pneumoniae Infection. Front Aging 2021;2:798868. [PMID: 35291600 DOI: 10.3389/fragi.2021.798868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Luck JN, Tettelin H, Orihuela CJ. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front Cell Infect Microbiol 2020;10:613287. [PMID: 33425786 DOI: 10.3389/fcimb.2020.613287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
73 Zarrella TM, Bai G. The Many Roles of the Bacterial Second Messenger Cyclic di-AMP in Adapting to Stress Cues. J Bacteriol 2020;203:e00348-20. [PMID: 32839175 DOI: 10.1128/JB.00348-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
74 Kann S, Sao S, Phoeung C, By Y, Bryant J, Komurian-Pradel F, Saphonn V, Chou M, Turner P. MALDI-TOF mass spectrometry for sub-typing of Streptococcus pneumoniae. BMC Microbiol 2020;20:367. [PMID: 33261551 DOI: 10.1186/s12866-020-02052-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Badgujar DC, Anil A, Green AE, Surve MV, Madhavan S, Beckett A, Prior IA, Godsora BK, Patil SB, More PK, Sarkar SG, Mitchell A, Banerjee R, Phale PS, Mitchell TJ, Neill DR, Bhaumik P, Banerjee A. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle. PLoS Pathog 2020;16:e1009016. [PMID: 33216805 DOI: 10.1371/journal.ppat.1009016] [Reference Citation Analysis]
76 Garcia-Garcia S, Perez-Arguello A, Henares D, Timoneda N, Muñoz-Almagro C. Rapid identification, capsular typing and molecular characterization of Streptococcus pneumoniae by using whole genome nanopore sequencing. BMC Microbiol 2020;20:347. [PMID: 33187472 DOI: 10.1186/s12866-020-02032-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Panagiotou S, Chaguza C, Yahya R, Audshasai T, Baltazar M, Ressel L, Khandaker S, Alsahag M, Mitchell TJ, Prudhomme M, Kadioglu A, Yang M. Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity. Sci Rep 2020;10:17313. [PMID: 33057054 DOI: 10.1038/s41598-020-73454-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Onwuchekwa C, Edem B, Williams V, Oga E. Estimating the impact of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: A systematic review. F1000Res 2020;9:765. [PMID: 33335713 DOI: 10.12688/f1000research.25227.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]